MiR-200-a-3p has also been shown to facilitate bladder cancer cell proliferation, metastasis of non-small cell lung cancer cells, and proliferation of esophageal cancer cells by targeting the A20 gene, downregulating SOX17, and by post-transcriptionally regulating cytoplasmic collapsing response mediator protein-1, respectively [44,45,46]. This evidence concerns the gene SOX17 and urinary bladder carcinoma.